Walk In Drive Goa Job Location Chhatrapati Sambhajinagar (Aurangabad)

We at Glenmark Pharmaceuticals Ltd. are hiring for various positions in Manufacturing, Quality Function for Chhatrapati Sambhajinagar Site. Candidates having experience in External Preparation, sterile, liquid, spray, ointment, inhalation, nasal, etc. can walk in for interview on Sunday, 2nd June, 2024 at The Fern Kesarval Hotel, Verna Goa.

Walk In Drive Goa Job Location: Chhatrapati Sambhajinagar (Aurangabad)

Walk-In Interviews for Production, Quality Assurance & Quality Control for Glenmark Pharmaceuticals Ltd.

Production: Junior Officer (Operator), Officer, Sr. Officer

Profile: Experience in Production areas such as: Sterile, External preparations, Liquids, Inhalations, Nasal.

Qualification: D. Pharma/ITI/B.Sc./B. Pharm/M. Pharm.

Experience: 02 Years to 08 Years

Quality Assurance & Quality Control:

 Officer/Senior Officer/Executive

Profile: QA: IPQA, documentation, change control, CAPA, QMS.

QC: Analysis of Raw material, Stability and Finished product samples, must have hands on experience of instruments like, HPLC, GC, UV, KF, ICPMS & IR.

Qualification: B. Pharm/M. Pharm./M.Sc.

Experience: 03 Years to 08 Years

Date: 2nd June 2024, Sunday

Venue: The Fern Kesarval Hotel, Verna Goa

Note

1) Interested candidates having relevant background from Regulatory plants may attend Walk-in interview with copy of updated resume, latest CTC breakup and Passport size photographs, Pan & Aadhar Card (xerox set for submission).

2) If unable to come may email their CV's on aurangabad.reception@glenmarkpharma.com

Disclaimer: Glenmark follows the formal process of recruitment through its own HR Department and do not oumource the final selection of our prospective employees to any individual, agency or consultants. We do not ask for any registration fees of security deposit (refundable or non-refundablej at any stage of recruitment process.

#remotejobs #fresher #fresherjobs #clinicalresearch #bpharm #thedrugindex #mpharm #pharmd #bsc #msc #pharma #pharmacovigilance #vacancy #reference #wfh #bds #biotechnology #bams #bhms #lifescience

This Disclaimer is for side owner : We're not affiliated with the company. At Mission Helping Hands

Company Information

Global pharmaceutical firm Glenmark Pharmaceuticals Limited is driven by research and operates in the branded, generic, and over-the-counter (OTC) markets. Its primary focus is on respiratory, dermatological, and oncology therapies. The corporation operates in more than 80 countries and has four R&D centers in addition to 10 top-notch manufacturing facilities dispersed over five continents. Glenmark is following two different routes in its effort to be one of the first few Indian pharmaceutical companies to create a novel medication for the global market. The goal is to find a new chemical or biological entity. The second one addresses treatment gaps and leads to the expansion of the value chain through the development of specialty goods like RYALTRIS.

Together, Glenmark Pharmaceuticals and its completely owned US subsidiary Ichnos Sciences have established a partnership called Ichnos Glenmark Innovation to treat cancer using a variety of modalities, cutting-edge technology, and their combined experience. It has a strong pipeline of novel compounds in oncology and immunology that are in different phases of clinical development. Glenmark is propelled by an unwavering dedication to establishing "A New Way for a New World." We continue to be committed to persistently challenging accepted treatment paradigms by utilizing the potential of our fundamental capabilities, which include innovation, research, and scientific understanding. It enables us to find and provide potential treatments that significantly improve patients' lives across a range of geographic locations.

Working together spurs innovation Together, Ichnos and Glenmark form 'Ichnos Glenmark Innovation,' an association that aims to expedite innovation in the search for a cancer treatment. Through this partnership, Ichnos and Glenmark's strengths in drug creation will be combined to create innovative treatments for solid tumors and hematological malignancies.

ESTABLISHING A BUSINESS WITH TRANSPARENCY AND ETHICS The foundation of Glenmark is knowledge, respect, and achievement. At Glenmark, we are dedicated to expanding upon our core beliefs and do business with the highest ethical standards. Guidelines for Behavior The cornerstone of our corporate governance, the Glenmark Code sets down the rules that guide us in a dynamic business environment. The Glenmark Code establishes the highest standards for ethical behavior in the marketplace, which directs our operations.

The CSR division of Glenmark Pharmaceuticals, the Glenmark Foundation, is dedicated to enhancing child health and lowering infant and child mortality. We have created a whole 360° approach to child health, with the underlying goal of "Healthier Children, Healthier World." With the help of our flagship program, Project Kavach, we are genuinely getting closer to achieving our goal. The primary focus of Project Kavach is on maternal and child health interventions in Himachal Pradesh, Gujarat, Maharashtra, Madhya Pradesh, and Sikkim, among other Indian states. Our programs are aimed at encouraging expectant and nursing mothers to seek health care, increasing public knowledge of good nutrition and hygiene habits, and guaranteeing that these women have access to necessary medical services.

improving the quality of life in approximately 165 villages Sanganer, Rajasthan Our goal is to address child health issues through our interventions, which include training and capacity building of front line workers and caregivers, counseling and monitoring during home visits, health camps, and reinforcement through street plays and school rallies. We work with our non-governmental partner, the Society for Integrated Development Activities, Research & Training (SIDART) in Rajasthan. Immunization calendars and colored beads, for example, are two interventions that have been incredibly effective in promoting healthy behavior while also lowering malnutrition and raising vaccination knowledge. Over 81,000 people have benefited directly from our various sanitation efforts, and an additional 15,000 people have benefited indirectly.